Search

Introduction: While detecting active TB is central to public health efforts, modelling indicates that reducing latent TB through preventive therapy is crucial. Current regimens mitigate risk but are lengthy and have side effects, necessitating support for uninterrupted treatment. This paper presents the development and evaluation of a digital health platform designed to enhance adherence among LTBI patients. Methods: A Quasi-experimental study was conducted among LTBI patients in Delhi. A total of 163 participants were allocated to intervention (n=82) and control (n=81) groups. Participants were followed up for 6 months post recruitment. Effectiveness of mobile application was evaluated through quantitative tools. Results: Intervention group participants showed slightly higher treatment completion rates (65.91%), in comparison to participants in control group (63%). The analysis demonstrated no co-relation of gender, age, education and employment with treatment completion rates in intervention group. While text and video-based interventions have shown success, there remains a need for more user-centric digital health interventions in this area, given the limited number of studies to date. Conclusion: The mobile health applications can be useful for LTBI care. However, there is a need of involving users during development so that continued interest of users can be ensured.

Objective: To investigate the neuroprotective action of hordenine against the cognitive dysfunction induced by aluminium chloride (AlCl3) in Wistar rats Methodology: Rats were given oral doses of hordenine (25 and 50 mg/kg), donepezil (5 mg/kg), and AlCl3 (175 mg/kg) for 28 days. During the study, neurobehavioral parameters included Morris water maze (MWM), open field test (OFT), and novel object recognition test (NORT) to assess the cognitive effect. On the 29th day rats were sacrificed and brain tissues removed for biochemical and histopathological analyses. Results: AlCl3 rats exhibited altered neurobehavioral patterns and cognitive impairment in experimental rats. Although AlCl3 raised the levels of mid-brain acetylcholinesterase (AChE), lipid peroxidation (LPO), nitrite, tumour necrosis factor-α (TNF-α), interleukin-β (IL-β), nuclear factor-kappa B (NF-κB), brain-derived neurotrophic factor (BDNF), and it decreased the levels of antioxidants including glutathione (GSH), catalase, superoxide dismutase (SOD), and body weight. In cortical and hippocampal slices, AlCl3 also revealed anatomical alterations that resulted in a decrease in the density of microglia. But donepezil and hordenine reversed these alterations to normal while demonstrating a neuroprotective effect against AD which is caused by AlCl3. Conclusion: Hordenine improved memory and other cognitive functions, demonstrating a neuroprotective effect against AlCl3-induced Alzheimer's disease. These findings imply that hordenine may be able to reverse the effects of oxidative stress and neuroinflammation, improve cognitive decline, and protect the brain's histological structure.